Advanced search
Publication Cover
Journal of Medical Economics Volume 27, 2024 - Issue 1
Submit an article Journal homepage
905
Views
0
CrossRef citations to date
0
Altmetric
Oncology

Cost-effectiveness of pembrolizumab for previously treated MSI-H/dMMR solid tumours in the UK

Grant McCarthya MSD (UK) Ltd, London, UKCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-8292-8598
ORCID Icon,
Kate Youngb Merck & Co., Inc, Rahway, NJ, USAORCID Iconhttps://orcid.org/0000-0001-5637-9871
ORCID Icon,
Matthew Madin-Warburtonc Lumanity, London, UK
,
Tyler Mantaiand Lumanity, Las Vegas, NV, USA
,
Elizabeth Brookc Lumanity, London, UK
,
Kaylie Metcalfec Lumanity, London, UK
,
Jan Mikelsone MSD, Zurich, SwitzerlandORCID Iconhttps://orcid.org/0000-0001-5233-4756
ORCID Icon,
Ruifeng Xub Merck & Co., Inc, Rahway, NJ, USA
,
Carl Seyla-Hammera MSD (UK) Ltd, London, UK
,
Raquel Aguiar-Ibáñezf Merck Canada Inc, Kirkland, QC, CanadaORCID Iconhttps://orcid.org/0000-0002-3839-6966
ORCID Icon &
Mayur Amonkarb Merck & Co., Inc, Rahway, NJ, USA
 show all
Pages 279-291 | Received 21 Nov 2023, Accepted 25 Jan 2024, Published online: 19 Feb 2024

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.